Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1997 2
1998 1
1999 1
2000 2
2002 3
2003 1
2007 1
2010 1
2013 3
2014 2
2015 4
2016 1
2017 2
2018 1
2019 1
2020 2
2021 1
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Postoperative hyperkalemia.
Ayach T, Nappo RW, Paugh-Miller JL, Ross EA. Ayach T, et al. Among authors: nappo rw. Eur J Intern Med. 2015 Mar;26(2):106-11. doi: 10.1016/j.ejim.2015.01.010. Epub 2015 Feb 17. Eur J Intern Med. 2015. PMID: 25698564 Review.
The pathophysiologic basis of diverse causes of hyperkalemia was used to broadly classify etiologies into those with altered potassium distribution (e.g. increased potassium release from cells or other transcellular shifts), reduced urinary excretion (e.g. reduced s …
The pathophysiologic basis of diverse causes of hyperkalemia was used to broadly classify etiologies into those with altered potassium distr …
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
Simbolo M, Silvestris N, Malleo G, Mafficini A, Maggino L, Cocomazzi A, Veghini L, Mombello A, Pezzini F, Sereni E, Martelli FM, Gkountakos A, Ciaparrone C, Piredda ML, Ingravallo G, Paolino G, Nappo F, Rapposelli IG, Frassinetti L, Saragoni L, Lonardi S, Pea A, Paiella S, Fassan M, Brunetti O, Cingarlini S, Salvia R, Milella M, Corbo V, Lawlor RT, Scarpa A, Luchini C. Simbolo M, et al. Among authors: nappo f. Mod Pathol. 2023 Sep;36(9):100251. doi: 10.1016/j.modpat.2023.100251. Epub 2023 Jun 22. Mod Pathol. 2023. PMID: 37355152 Free article.
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study.
Ruggeri RM, Altieri B, Razzore P, Retta F, Sperti E, Scotto G, Brizzi MP, Zumstein L, Pia A, Lania A, Lavezzi E, Nappo G, Laffi A, Albertelli M, Boschetti M, Hasballa I, Veresani A, Prinzi N, Pusceddu S, Oldani S, Nichetti F, Modica R, Minotta R, Liccardi A, Cannavale G, Grossrubatscher EM, Tarsitano MG, Zamponi V, Zatelli MC, Zanata I, Mazzilli R, Appetecchia M, Davì MV, Guarnotta V, Giannetta E, La Salvia A, Fanciulli G, Malandrino P, Isidori AM, Colao A, Faggiano A; NIKE Group. Ruggeri RM, et al. Among authors: nappo g. J Endocrinol Invest. 2024 Apr;47(4):959-971. doi: 10.1007/s40618-023-02213-1. Epub 2023 Oct 14. J Endocrinol Invest. 2024. PMID: 37837555 Free PMC article.
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas.
Gkountakos A, Mafficini A, Lou E, Malleo G, Salvia R, Calicchia M, Silvestris N, Racila E, Amin K, Veronese N, Brunetti O, Antonini P, Ingravallo G, Mattiolo P, Saponaro C, Nappo F, Simbolo M, Bariani E, Lonardi S, Fassan M, Milella M, Lawlor RT, Scarpa A, Luchini C. Gkountakos A, et al. Among authors: nappo f. Hum Pathol. 2022 Oct;128:124-133. doi: 10.1016/j.humpath.2022.07.011. Epub 2022 Jul 16. Hum Pathol. 2022. PMID: 35850360
["Getting to zero infections" in hemodialysis].
Leonardi G, Finotto G, Talaia M, Nappo A, Dolla C, Di Vico MC, Diena D, Linsalata A, Guarena C, Barbaro S, Biancone L. Leonardi G, et al. Among authors: nappo a. G Ital Nefrol. 2015 Sep-Oct;32(5):gin/32.5.4. G Ital Nefrol. 2015. PMID: 26480255 Italian.
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.
Lavezzi E, Brunetti A, Smiroldo V, Nappo G, Pedicini V, Vitali E, Trivellin G, Mazziotti G, Lania A. Lavezzi E, et al. Among authors: nappo g. Front Endocrinol (Lausanne). 2022 Mar 9;13:773143. doi: 10.3389/fendo.2022.773143. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35355569 Free PMC article. Review.
The second report is about a 76-year-old woman with a multifocal pancreatic G1-NET. Genetic analysis identified the CDKN1B mutation c.482C>G (p.S161C), described here for the first time in association with MEN4 and currently classified as a variant of uncertain signific …
The second report is about a 76-year-old woman with a multifocal pancreatic G1-NET. Genetic analysis identified the CDKN1B mutation c.482C&g …
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases.
Vanoli A, Grami O, Klersy C, Milanetto AC, Albarello L, Fassan M, Luchini C, Grillo F, Spaggiari P, Inzani F, Uccella S, Parente P, Nappo G, Mattiolo P, Milione M, Pietrabissa A, Cobianchi L, Schiavo Lena M, Partelli S, Di Sabatino A, Sempoux C, Capella C, Pasquali C, Doglioni C, Sessa F, Scarpa A, Rindi G, Paulli M, Zerbi A, Falconi M, Solcia E, La Rosa S. Vanoli A, et al. Among authors: nappo g. Endocr Pathol. 2022 Jun;33(2):274-288. doi: 10.1007/s12022-022-09720-6. Epub 2022 May 13. Endocr Pathol. 2022. PMID: 35553369 Free PMC article.
Use of the esa resistance index to guide dosing for anaemia management.
Ross EA, Paugh-Miller JL, Wen X, Nappo RW. Ross EA, et al. Among authors: nappo rw. J Ren Care. 2020 Dec;46(4):216-221. doi: 10.1111/jorc.12324. Epub 2020 Mar 27. J Ren Care. 2020. PMID: 32219971
BACKGROUND: Identifying erythropoiesis-stimulating agent (ESA) resistance is important for treating reversible causes, reaching target haemoglobin levels with minimal dosing, avoiding adverse effects and reducing costs. The resistance index (RI, dose/kg weight/g haemoglobi …
BACKGROUND: Identifying erythropoiesis-stimulating agent (ESA) resistance is important for treating reversible causes, reaching target haemo …
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials.
Dell'Aquila E, Rossini D, Fulgenzi CAM, Passardi A, Tamburini E, Vetere G, Carullo M, Citarella F, Antoniotti C, Zaniboni A, Pietrantonio F, Spagnoletti A, Marmorino F, Borelli B, Allegrini G, Lonardi S, Nappo F, Masi G, Cremolini C, Santini D. Dell'Aquila E, et al. Among authors: nappo f. ESMO Open. 2022 Dec;7(6):100606. doi: 10.1016/j.esmoop.2022.100606. Epub 2022 Oct 31. ESMO Open. 2022. PMID: 36327757 Free PMC article.
34 results